Open AccessNatalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Author(s) -
Wei Zhen Yeh,
Putu Ayu Widyastuti,
Anneke van der Walt,
Jim Stankovich,
Eva Havrdová,
Dana Horáková,
Karolína Vodehnalová,
Serkan Özakbaş,
Sara Eichau,
Pierre Duquette,
Tomáš Kalinčík,
Francesco Patti,
Cavit Boz,
Murat Terzı,
Bassem Yamout,
Jeannette LechnerScott,
Patrizia Sola,
Olga Skibina,
Michael Barnett,
Marco Onofrj,
María José Sá,
Pamela McCombe,
Pierre Grammond,
Radek Ampapa,
François Grand’Maison,
Roberto Bergamaschi,
Daniele Spitaleri,
Vincent Van Pesch,
Elisabetta Cartechini,
Suzanne Hodgkinson,
Aysun Soysal,
Albert Sáiz,
Melissa Gresle,
Tomáš Uher,
Davide Maimone,
Recai Türkoğlu,
Raymond Hupperts,
Maria Pia Amato,
Franco Granella,
Celia OrejaGuevara,
Ayse Altıntaş,
Richard Macdonell,
Tamara Castillo-Triviño,
Helmut Butzkueven,
Raed Alroughani,
Vilija Jokubaitis
Publication year - 2021
Publication title -
neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.91
H-Index - 364
eISSN - 1526-632X
pISSN - 0028-3878
DOI - 10.1212/wnl.0000000000012084
Subject(s) - natalizumab , medicine , fingolimod , pregnancy , multiple sclerosis , obstetrics , postpartum period , cohort , immunology , genetics , biology
To investigate pregnancy-related disease activity in a contemporary multiple sclerosis (MS) cohort.